Select a community
HIV
Find out more about the PatientsLikeMe
HIV Community
Home > Community Treatment Reports > Loperamide Treatment Report
What is Loperamide?

A tablet, liquid or capsule taken to control diarrhea. Usually is taken immediately after each loose bowel movement but also can be taken on schedule. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken
# of patients Efficacy
Major
Moderate
Slight
None
Can’t tell 		# of patients evaluated by
Diarrhea 10 1
Support another treatment 2 0
Other 1 0

See all 14 patients currently taking Loperamide

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
1 100%

Dosages

  1 as needed 2 mg as needed 2mg as needed 4 mg as needed 2 mg daily 4 mg daily 6 mg daily 8 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2  

Stop Reasons

Why Patients Stopped Taking Loperamide (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended
1 100% Course of treatment ended: 100%

See all 1 patient who’ve stopped taking Loperamide

Duration See details about how long patients take this treatment ▼

Currently Taking Loperamide

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Loperamide

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
1 100%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 100%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 20, 2010.